After Hours Summary: NVDA +0.8% extending gains further in after hours trade, MDXG +2% on Aetna EpiFix coverage news... ANTH -67% as Phase 3 study narrow miss causes big dropAfter Hours Gainers:
Companies trading higher in after hours in reaction to news:
- CEMP +3.4% (light volume, closed down 5% on the day)
- MDXG +1.8% (EpiFix product has received coverage from insurer Aetna)
- IRG +1.6% (extending today's 85%+ move higher)
- CETX +0.9% (will launch previously announced $15.0 million subscription rights offering tomorrow)
- NVDA +0.8% (continued strength)
After Hours Losers:
Companies trading lower in after hours in reaction to news:
- ANTH -66.7% (announces top line results of the SOLUTION clinical study in cystic fibrosis patients with exocrine pancreatic insufficiency; study 'narrowly missed' CFA non-inferiority margin of the primary modified Intent to Treat analysis)
- ACAD -1% (after relinquishing early gains and closing near lows -- down 2.7% on the day)
- HTZ -0.2% (Glenview Capital lowers passive stake)